M

Mankind Pharma Ltd
NSE:MANKIND

Watchlist Manager
Mankind Pharma Ltd
NSE:MANKIND
Watchlist
Price: 2 172.1 INR 1.41% Market Closed
Market Cap: 896.7B INR

Wall Street
Price Targets

MANKIND Price Targets Summary
Mankind Pharma Ltd

Wall Street analysts forecast MANKIND stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MANKIND is 2 694.98 INR with a low forecast of 2 171.5 INR and a high forecast of 3 423 INR.

Lowest
Price Target
2 171.5 INR
0% Downside
Average
Price Target
2 694.98 INR
24% Upside
Highest
Price Target
3 423 INR
58% Upside
Mankind Pharma Ltd Competitors:
Price Targets
LQDA
Liquidia Corp
30% Upside
KILITCH
Kilitch Drugs (India) Ltd
40% Upside
SECARE
Swedencare AB (publ)
34% Upside
CRON
Cronos Group Inc
26% Upside
300119
Tianjin Ringpu Bio-Technology Co Ltd
36% Upside
ANIP
ANI Pharmaceuticals Inc
34% Upside
1681
Consun Pharmaceutical Group Ltd
21% Upside
NAVA
Navamedic ASA
41% Upside

Revenue
Forecast

Revenue Estimate
Mankind Pharma Ltd

For the last 4 years the compound annual growth rate for Mankind Pharma Ltd's revenue is 18%. The projected CAGR for the next 3 years is 15%.

18%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Mankind Pharma Ltd

For the last 4 years the compound annual growth rate for Mankind Pharma Ltd's operating income is 12%. The projected CAGR for the next 3 years is 19%.

12%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Mankind Pharma Ltd

For the last 4 years the compound annual growth rate for Mankind Pharma Ltd's net income is 12%. The projected CAGR for the next 3 years is 18%.

12%
Past Growth
18%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MANKIND's stock price target?
Price Target
2 694.98 INR

According to Wall Street analysts, the average 1-year price target for MANKIND is 2 694.98 INR with a low forecast of 2 171.5 INR and a high forecast of 3 423 INR.

What is Mankind Pharma Ltd's Revenue forecast?
Projected CAGR
15%

For the last 4 years the compound annual growth rate for Mankind Pharma Ltd's revenue is 18%. The projected CAGR for the next 3 years is 15%.

What is Mankind Pharma Ltd's Operating Income forecast?
Projected CAGR
19%

For the last 4 years the compound annual growth rate for Mankind Pharma Ltd's operating income is 12%. The projected CAGR for the next 3 years is 19%.

What is Mankind Pharma Ltd's Net Income forecast?
Projected CAGR
18%

For the last 4 years the compound annual growth rate for Mankind Pharma Ltd's net income is 12%. The projected CAGR for the next 3 years is 18%.

Back to Top